title: Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
authors.affiliation: Saint-Louis Hospital, Paris.
authors.forename: G
authors.initials: G
authors.lastname: Schaison
authors.forename: D
authors.initials: D
authors.lastname: Sommelet
authors.forename: A
authors.initials: A
authors.lastname: Bancillon
authors.forename: Y
authors.initials: Y
authors.lastname: Perel
authors.forename: T
authors.initials: T
authors.lastname: Leblanc
authors.forename: C
authors.initials: C
authors.lastname: Bergeron
authors.forename: O
authors.initials: O
authors.lastname: Lejars
authors.forename: A
authors.initials: A
authors.lastname: Baruchel
authors.forename: E
authors.initials: E
authors.lastname: Lepage
authors.forename: G
authors.initials: G
authors.lastname: Leverger
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence; D012074:Remission Induction; D012307:Risk Factors; D014750:Vincristine / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003520:Cyclophosphamide; D001215:Asparaginase; D014751:Vindesine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin